ARTIDIS AG is a clinical-stage health-tech start-up founded in Basel, Switzerland, that has developed the first nanomechanical biomarker for cancer diagnosis and treatment optimization. The ARTIDIS nanotechnology platform integrates different types of clinical data into the ARTIDISNET
Sentec is a Swiss-American medical device company specializing in respiratory care. Since its founding in 1999 the company utilizes a deep-tech approach that is founded on advanced science and avant-garde technologies for respiratory patients across care areas.
Visium combines strategy, frontier AI, and deep regulated-industry expertise to build and deploy AI-native systems that reinvent how businesses operate - unlocking the value of AI at scale. Were not a strategy firm that ships slide
Job Details Deskside Technician II Job Description Working in a fast paced, constantly evolving environment, you will be responsible for providing a high level of customer service and hands-on support. This is a fantastic opportunity to
Basel Area Business & Innovation is the economic promotion agency for the Basel Area and the strategic growth partner helping scalable ventures in science and tech to land, launch and level up in the Basel Area -
About us GRANITE BIO is a private biotechnology company located in Basel (Switzerland). GRANITE BIO is supported by top-tier investors with ~$100M raised to date. Based on fundamental research conducted over the last two decades, GRANITE
Your Tasks You structure and negotiate complex media deals, optimize pricing models, and drive revenue growth with a strong commercial and results-oriented mindset. Consistently hit your individual revenue target and help deliver team objectives. You develop
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
About us GRANITE BIO is a private biotechnology company located in Basel (Switzerland). It is supported by top‑tier investors with approximately $100M raised to date. Building on fundamental research conducted over the last two decades, GRANITE
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Special Everyday – that is our promise, and we base our service on it. With the values of team spirit, agility and customer focus that shape our work, we are making Manor the number 1 omnichannel